House Committee Report
Underlined text would be added to current law. Struck-through text would be removed.
| 89R24623 RDS-D | ||
| By: Darby, Craddick, Harris, Harless, Rose, | H.B. No. 3265 | |
| et al. | ||
| Substitute the following for H.B. No. 3265: | ||
| By: Dean | C.S.H.B. No. 3265 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to discriminatory practices by a health benefit plan | |
| issuer, pharmacy benefit manager, and third-party payor and certain | |
| prescription drug manufacturers, distributors, and related persons | |
| with respect to certain entities participating in a federal drug | |
| discount program; providing a civil penalty. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subchapter N, Chapter 431, Health and Safety | |
| Code, is amended by adding Section 431.416 to read as follows: | |
| Sec. 431.416. DISCRIMINATION WITH RESPECT TO FEDERAL 340B | |
| DRUG DISCOUNT PROGRAM PROHIBITED. (a) In this section: | |
| (1) "340B drug" and "covered entity" have the meanings | |
| assigned by Section 1369.701, Insurance Code. | |
| (2) "Package" has the meaning assigned by 21 U.S.C. | |
| Section 360eee(11)(A). | |
| (3) "Pharmacist" and "pharmacy" have the meanings | |
| assigned by Section 551.003, Occupations Code. | |
| (b) Except as provided by Subsections (c) and (d), a | |
| manufacturer, repackager, logistics provider, third-party | |
| logistics provider, wholesale distributor, or agent of a | |
| prescription drug may not, either directly or indirectly: | |
| (1) discriminate against a covered entity, a | |
| pharmacist or pharmacy that is under contract with the covered | |
| entity, or another entity that is authorized under the contract to | |
| receive the drug on behalf of the covered entity; | |
| (2) deny, restrict, prohibit, or otherwise limit the | |
| acquisition of a 340B drug by, or delivery of the drug to, a covered | |
| entity, a pharmacist or pharmacy that is under contract with the | |
| covered entity, or another entity that is authorized under the | |
| contract to receive the drug on behalf of the covered entity; or | |
| (3) require a covered entity, a pharmacist or pharmacy | |
| that is under contract with the covered entity, or another entity | |
| that is authorized under the contract to receive a 340B drug on | |
| behalf of the covered entity to submit any claim or utilization data | |
| as a condition for the acquisition of a 340B drug by, or delivery of | |
| a 340B drug to, the covered entity, pharmacist or pharmacy under | |
| contract with the covered entity, or other entity authorized to | |
| receive the drug, as applicable. | |
| (c) This section does not apply to: | |
| (1) the receipt of a 340B drug that is prohibited by | |
| the United States Food and Drug Administration; | |
| (2) the submission of a claim or utilization data that | |
| is required by the United States Department of Health and Human | |
| Services or the department; or | |
| (3) the Texas HIV medication program established under | |
| Section 85.061. | |
| (d) Subsection (b)(3) does not apply to a pharmaceutical | |
| manufacturer audit that: | |
| (1) pertains directly to a covered entity's compliance | |
| with the requirements of 42 U.S.C. Section 256b(a)(5)(A)(i) or | |
| (a)(5)(B); and | |
| (2) is conducted in accordance with procedures | |
| established by the United States Department of Health and Human | |
| Services. | |
| (e) A person who has reasonable cause to believe another | |
| person has violated this section may submit a complaint to the | |
| department. The department may investigate the complaint. If the | |
| department finds that the person subject to the complaint committed | |
| a violation of this section, the department: | |
| (1) shall refer the complaint to the attorney general; | |
| and | |
| (2) may, in accordance with Section 431.414, suspend | |
| or revoke a license issued under this subchapter and held by the | |
| person subject to the complaint. | |
| (f) A person who violates this section commits a false, | |
| misleading, or deceptive act or practice under Section 17.46, | |
| Business & Commerce Code, except that a civil penalty may be | |
| assessed in an amount not greater than $50,000 for each violation. A | |
| person commits a separate violation for each package of 340B drugs | |
| that is the subject of a violation of this section. | |
| (g) The executive commissioner shall adopt rules necessary | |
| to implement this section. | |
| (h) This section does not create a private cause of action | |
| against a person who violates this section. | |
| (i) Nothing in this section may be construed or applied to | |
| be: | |
| (1) less restrictive than any federal law as to any | |
| person regulated by this section; or | |
| (2) in conflict with: | |
| (A) federal law or a related regulation; or | |
| (B) any law of this state that is compatible with | |
| applicable federal law. | |
| SECTION 2. Chapter 1369, Insurance Code, is amended by | |
| adding Subchapter O to read as follows: | |
| SUBCHAPTER O. PROHIBITION ON DISCRIMINATION WITH RESPECT TO | |
| FEDERAL 340B DRUG DISCOUNT PROGRAM | |
| Sec. 1369.701. DEFINITIONS. In this subchapter: | |
| (1) "340B drug" means a covered outpatient drug within | |
| the meaning of 42 U.S.C. Section 256b that has been subject to any | |
| offer for reduced prices by a manufacturer under the 340B program | |
| and is purchased, or is intended to be purchased, by a covered | |
| entity. | |
| (2) "340B program" means the federal drug discount | |
| program established by Section 340B, Public Health Service Act (42 | |
| U.S.C. Section 256b). | |
| (3) "Covered entity" has the meaning assigned by 42 | |
| U.S.C. Section 256b(a)(4). | |
| (4) "Manufacturer" has the meaning assigned by Section | |
| 431.401, Health and Safety Code. | |
| (5) "Non-covered entity" means an entity that is not a | |
| covered entity. | |
| (6) "Pharmacy benefit manager" has the meaning | |
| assigned by Section 4151.151. | |
| (7) "Third-party payor" means any person, other than a | |
| pharmacy benefit manager, health benefit plan issuer, patient, or | |
| individual paying for a patient's drugs on the patient's behalf, | |
| that makes payment for drugs dispensed by a pharmacist or pharmacy | |
| or administered by a health care professional. | |
| Sec. 1369.702. APPLICABILITY OF SUBCHAPTER. (a) This | |
| subchapter applies only to a health benefit plan that provides | |
| benefits for medical or surgical expenses incurred as a result of a | |
| health condition, accident, or sickness, including an individual, | |
| group, blanket, or franchise insurance policy or insurance | |
| agreement, a group hospital service contract, or an individual or | |
| group evidence of coverage or similar coverage document that is | |
| issued by: | |
| (1) an insurance company; | |
| (2) a group hospital service corporation operating | |
| under Chapter 842; | |
| (3) a health maintenance organization operating under | |
| Chapter 843; | |
| (4) an approved nonprofit health corporation that | |
| holds a certificate of authority under Chapter 844; | |
| (5) a multiple employer welfare arrangement that holds | |
| a certificate of authority under Chapter 846; | |
| (6) a stipulated premium company operating under | |
| Chapter 884; | |
| (7) a fraternal benefit society operating under | |
| Chapter 885; | |
| (8) a Lloyd's plan operating under Chapter 941; or | |
| (9) an exchange operating under Chapter 942. | |
| (b) Notwithstanding any other law, this subchapter applies | |
| to: | |
| (1) a small employer health benefit plan subject to | |
| Chapter 1501, including coverage provided through a health group | |
| cooperative under Subchapter B of that chapter; | |
| (2) a standard health benefit plan issued under | |
| Chapter 1507; | |
| (3) a basic coverage plan under Chapter 1551; | |
| (4) a basic plan under Chapter 1575; | |
| (5) a primary care coverage plan under Chapter 1579; | |
| (6) a plan providing basic coverage under Chapter | |
| 1601; | |
| (7) alternative health benefit coverage offered by a | |
| subsidiary of the Texas Mutual Insurance Company under Subchapter | |
| M, Chapter 2054; | |
| (8) group health coverage made available by a school | |
| district in accordance with Section 22.004, Education Code; | |
| (9) a regional or local health care program operated | |
| under Section 75.104, Health and Safety Code; | |
| (10) a self-funded health benefit plan sponsored by a | |
| professional employer organization under Chapter 91, Labor Code; | |
| (11) county employee group health benefits provided | |
| under Chapter 157, Local Government Code; and | |
| (12) health and accident coverage provided by a risk | |
| pool created under Chapter 172, Local Government Code. | |
| Sec. 1369.703. EXCEPTIONS. This subchapter does not apply | |
| to: | |
| (1) the state Medicaid program, including the Medicaid | |
| managed care program operated under Chapter 540, Government Code; | |
| or | |
| (2) the Texas HIV medication program established under | |
| Section 85.061, Health and Safety Code. | |
| Sec. 1369.704. PROHIBITION ON DISCRIMINATORY ACTIONS. (a) | |
| Except as provided by Subsection (b), a health benefit plan issuer, | |
| pharmacy benefit manager, or third-party payor may not: | |
| (1) reimburse a covered entity or a pharmacist or | |
| pharmacy that is under contract with the entity for a prescription | |
| drug at a rate lower than the rate paid to a non-covered entity for | |
| the same drug; | |
| (2) require a covered entity or a pharmacy or | |
| pharmacist under contract with the entity to include with a claim | |
| for a prescription drug dispensed by the entity an identification, | |
| billing modifier, attestation, or other indication that the drug is | |
| a 340B drug in order to be processed or resubmitted; | |
| (3) impose a term on a covered entity that differs from | |
| the terms applied to non-covered entities on the basis that the | |
| entity is a covered entity, including: | |
| (A) a fee, chargeback, or other adjustment that | |
| is not placed on non-covered entities; or | |
| (B) a restriction or requirement regarding | |
| participation in a health benefit plan issuer, pharmacy benefit | |
| manager, or third-party payor network, including a requirement that | |
| a covered entity enter into a contract with a specific pharmacy or | |
| pharmacist; or | |
| (4) discriminate against, create a restriction | |
| applicable to, or impose an additional charge on a patient who | |
| chooses to receive a prescription drug from a covered entity. | |
| (b) Subsection (a)(2) does not apply to a reporting | |
| requirement imposed by the United States Department of Health and | |
| Human Services or the Department of State Health Services. | |
| SECTION 3. (a) Section 431.416, Health and Safety Code, as | |
| added by this Act, applies only to a prescription drug manufactured | |
| on or after the effective date of this Act. | |
| (b) Subchapter O, Chapter 1369, Insurance Code, as added by | |
| this Act, applies only to a health benefit plan delivered, issued | |
| for delivery, or renewed on or after January 1, 2026. | |
| SECTION 4. It is the intent of the legislature that every | |
| provision, section, subsection, sentence, clause, phrase, or word | |
| in this Act, and every application of the provisions in this Act to | |
| every person, group of persons, or circumstances, is severable from | |
| each other. If any application of any provision in this Act to any | |
| person, group of persons, or circumstances is found by a court to be | |
| invalid for any reason, the remaining applications of that | |
| provision to all other persons and circumstances shall be severed | |
| and may not be affected. | |
| SECTION 5. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.